Eugenii A. Rabiner
According to our database1,
Eugenii A. Rabiner
authored at least 27 papers
between 2002 and 2019.
Collaborative distances:
Collaborative distances:
Timeline
Legend:
Book In proceedings Article PhD thesis Dataset OtherLinks
On csauthors.net:
Bibliography
2019
Accuracy and reliability of [<sup>11</sup>C]PBR28 specific binding estimated without the use of a reference region.
NeuroImage, 2019
2014
PET neuroimaging: The elephant unpacks his trunk: Comment on Cumming: "PET neuroimaging: The white elephant packs his trunk?".
NeuroImage, 2014
2013
NeuroImage, 2013
2012
Identifying improved TSPO PET imaging probes through biomathematics: The impact of multiple TSPO binding sites in vivo.
NeuroImage, 2012
2011
Imaging dopamine receptors in humans with [<sup>11</sup>C]-(+)-PHNO: Dissection of D3 signal and anatomy.
NeuroImage, 2011
2010
Effect of cellular compartments on the binding of [<sup>3</sup>H](+)PhNO to the porcine D2/D3-DAR.
NeuroImage, 2010
A combined diffusion tensor imaging (DTI) and [11C]-(+)-PHNO positron emission tomography (PET) study to quantify dopamine D3/D2 receptors in pallidum.
NeuroImage, 2010
Within-subject comparison of the sensitivity of [<sup>11</sup>C]-(+)-PHNO and [<sup>11</sup>C]raclopride to amphetamine induced changes in endogenous dopamine in healthy human volunteers.
NeuroImage, 2010
A pseudo-reference region method applied to measurement of GlyT1 occupancy in human brain using [11C]GSK931145 and PET.
NeuroImage, 2010
PET imaging of dopamine D3 receptors in humans with [11C]-(+)-PHNO: dissection of PHNO signal using two highly selective D3 antagonists.
NeuroImage, 2010
Pharmacokinetic characterization of compounds with increased target residence times using PET.
NeuroImage, 2010
NeuroImage, 2010
Evaluation of the in vivo ED<sub>50</sub> for the PET Radioligand, [<sup>11</sup>C]GSK-215083, in Papio anubis.
NeuroImage, 2010
NeuroImage, 2010
Further validation of [<sup>11</sup>C]FLB 457 as a tool to measure prefrontal cortical DA release.
NeuroImage, 2010
Serotonin transporter polymorphisms (SLC6A4 insertion/deletion and rs25531) do not affect the availability of 5-HTT to [<sup>11</sup>C] DASB binding in the living human brain.
NeuroImage, 2010
Predicting the in vivo performance of TSPO PET radioligands using a biomathematical modelling approach.
NeuroImage, 2010
In vivo binding of antipsychotics to D3 and D2 receptors: A PET study in baboons with [11C]-(+)-PHNO.
NeuroImage, 2010
Association between serotonin transporter binding, physiological and environmental factors in healthy male subjects.
NeuroImage, 2010
PET evaluation of the TSPO ligands [F-18]FEPPA, [F-18]PRB06, and [F-18]PBR111 in nonhuman primate.
NeuroImage, 2010
Differentiation of the Mu-opioid ligand GSK1521498 from naltrexone using [11C]carfentanil PET and fMRI.
NeuroImage, 2010
Effect of amphetamine on mouse striatal binding of [<sup>11</sup>C]Raclopride using the Inveon small animal PET scanner.
NeuroImage, 2010
NeuroImage, 2010
2002
A Database of [<sup>11</sup>C]WAY-100635 Binding to 5-HT<sub>1A</sub> Receptors in Normal Male Volunteers: Normative Data and Relationship to Methodological, Demographic, Physiological, and Behavioral Variables.
NeuroImage, 2002